A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1)

Mechanisms of Development

Volumn 123, Issue 3, 2006, Pages 228-240

  Liu, Jianmin ^a   Ball, Sherry L ^b   Yang, Yuan ^a   Mei, Pinchao ^a   Zhang, Lei ^a   Shi, Haining ^c   Kaminski, Henry J ^d   Lemmon, Vance P ^e   Hu, Huaiyu ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

dystroglycan; Electroretinogram; Mouse model; Muscle eye brain disease; Neuronal migration; OmniBank; POMGnT1

Indexed keywords

ALPHA DYSTROGLYCAN; ISOENZYME; MESSENGER RNA; O MANNOSE 1,2 N ACETYLGLUCOSAMINYLTRANSFERASE; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE MODEL; ENZYME ACTIVITY; ENZYME POLYMORPHISM; EXON; GENE LOCUS; GENETIC MODEL; GLYCOSYLATION; KNOCKOUT MOUSE; MOUSE; MUSCLE EYE BRAIN DISEASE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BRAIN; BRAIN DISEASES; CEREBELLUM; DISEASE MODELS, ANIMAL; DYSTROGLYCANS; EYE DISEASES; FERTILITY; GLYCOSYLATION; HOMOZYGOTE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUSCULAR DYSTROPHY, ANIMAL; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROSENCEPHALON;

ANIMALIA;

EID: 33645971589     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mod.2005.12.003     Document Type: Article

References (43)

1. Barresi R., Michele D.E., Kanagawa M., Harper H.A., Dovico S.A., Satz J.S., et al. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat. Med. 10 (2004) 696-703
2. Beltran-Valero de Bernabe D., Currier S., Steinbrecher A., Celli J., van Beusekom E., van der Zwaag B., et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am. J. Hum. Genet. 71 (2002) 1033-1043
3. Beltran-Valero de Bernabe D., Voit T., Longman C., Steinbrecher A., Steinbrecher V., Straub V., et al. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J. Med. Genet. 41 5 (2004) e61
4. Brancaccio A. An adhesion molecule involved in muscular dystrophies: structural and functional analysis of dystroglycan domains. Ital. J. Biochem. 52 (2003) 51-54
5. Brown S.C., Fassati A., Popplewell L., Page A.M., Henry M.D., Campbell K.P., et al. Dystrophic phenotype induced in vitro by antibody blockade of muscle alpha-dystroglycan-laminin interaction. J. Cell Sci. 112 (1999) 209-216
6. Campell K.P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80 (1995) 675-679
7. Chiba A., Matsumura K., Yamada H., Inazu T., Shimizu T., Kusunoki S., et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J. Biol. Chem. 272 (1997) 2156-2162
8. Cormand B., Avela K., Pihko H., Santavuori P., Talim B., Topaloglu H., et al. Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping. Am. J. Hum. Genet. 64 (1999) 126-135
9. Dubowitz V. The muscular dystrophies-clarity or chaos?. N. Engl. J. Med. 336 (1997) 650-651
10. Durbeej M., Henry M.D., and Campbell K.P. Dystroglycan in development and disease. Curr. Opin. Cell Biol. 10 (1998) 594-601
11. Endo T. O-Mannosyl glycans in mammals. Biochim. Biophys. Acta 1473 (1999) 237-246
12. Ervasti J.M., and Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122 (1993) 809-823
13. Fukuyama Y., Osawa M., and Suzuki H. Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations. Brain Dev. 3 (1981) 1-29
14. Grewal P.K., Holzfeind P.J., Bittner R.E., and Hewitt J.E. Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse. Nat. Genet. 28 2 (2001) 151-154
15. Hayashi Y.K., Ogawa M., Tagawa K., Noguchi S., Ishihara T., Nonaka I., et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 57 (2001) 115-121
16. Holzfeind P.J., Grewal P.K., Reitsamer H.A., Kechvar J., Lassmann H., Hoeger H., et al. Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large(myd) mouse defines a natural model for glycosylation-deficient muscle-eye-brain disorders. Hum. Mol. Genet. 11 (2002) 2673-2687
17. Hu H. Chemorepulsion of neuronal migration by Slit2 in the developing mammalian forebrain. Neuron 23 (1999) 703-711
18. Hu H. Polysialic acid regulates chain formation by migrating olfactory interneuron precursors. J. Neurosci. Res. 61 (2000) 480-492
19. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702
20. Kanagawa M., Saito F., Kunz S., Yoshida-Moriguchi T., Barresi R., Kobayashi Y.M., et al. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117 (2004) 953-964
21. Kobayashi K., Nakahori Y., Mizuno K., Miyake M., Kumagai T., Honma A., et al. Founder-haplotype analysis in Fukuyama-type congenital muscular dystrophy (FCMD). Hum. Genet. 103 (1998) 323-327
22. Lee Y., Kameya S., Cox G.A., Hsu J., Hicks W., Maddatu T.P., et al. Ocular abnormalities in Large(myd) and Large(vls) mice, spontaneous models for muscle, eye, and brain diseases. Mol. Cell. Neurosci. 30 (2005) 160-172
23. Liu J., Zhang L., Wang D., Shen H., Jiang M., Mei P., et al. Congenital diaphragmatic hernia, kidney agenesis and cardiac defects associated with Slit3-deficiency in mice. Mech. Dev. 120 (2003) 1059-1070
24. Lochter A., Vaughan L., Kaplony A., Prochiantz A., Schachner M., and Faissner A. J1/tenascin in substrate-bound and soluble form displays contrary effects on neurite outgrowth. J. Cell Biol. 113 (1991) 1159-1171
25. Longman C., Brockington M., Torelli S., Jimenez-Mallebrera C., Kennedy C., Khalil N., et al. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum. Mol. Genet. 12 (2003) 2853-2861
26. Manya H., Chiba A., Yoshida A., Wang X., Chiba Y., Jigami Y., et al. Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc. Natl Acad. Sci. USA 101 (2004) 500-505
27. Michele D.E., and Campbell K.P. Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J. Biol. Chem. 278 (2003) 15457-15460
28. Michele D.E., Barresi R., Kanagawa M., Saito F., Cohn R.D., Satz J.S., et al. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418 (2002) 417-422
29. Montanaro F., and Carbonetto S. Targeting dystroglycan in the brain. Neuron 37 (2003) 193-196
30. Moore S.A., Saito F., Chen J., Michele D.E., Henry M.D., Messing A., et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418 (2002) 422-425
31. Pillers D.A., Bulman D.E., Weleber R.G., Sigesmund D.A., Musarella M.A., Powell B.R., et al. Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nat Genet 4 (1993) 82-86
32. Santavuori P., Somer H., Sainio K., Rapola J., Kruus S., Nikitin T., et al. Muscle-eye-brain disease (MEB). Brain. Dev. 11 (1989) 147-153
33. Smalheiser N.R., and Kim E. Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties. J. Biol. Chem. 270 (1995) 15425-15433
34. Smalheiser N.R., Haslam S.M., Sutton-Smith M., Morris H.R., and Dell A. Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J. Biol. Chem. 273 (1998) 23698-23703
35. Strahl-Bolsinger S., Gentzsch M., and Tanner W. Protein O-mannosylation. Biochim. Biophys. Acta 1426 (1999) 297-307
36. Takahashi S., Sasaki T., Manya H., Chiba Y., Yoshida A., Mizuno M., et al. A new beta-1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology 11 (2001) 37-45
37. Takeda S., Kondo M., Sasaki J., Kurahashi H., Kano H., Arai K., et al. Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development. Hum. Mol. Genet. 12 (2003) 1449-1459
38. Taniguchi K., Kobayashi K., Saito K., Yamanouchi H., Ohnuma A., Hayashi Y.K., et al. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum. Mol. Genet. 12 (2003) 527-534
39. van Reeuwijk J., Janssen M., van den Elzen C., Beltran-Valero de Bernabe D., Sabatelli P., and Merlini L. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker Warburg syndrome. J. Med. Genet. (2005) (epub)
40. Willer T., Prados B., Falcon-Perez J.M., Renner-Muller I., Przemeck G.K., Lommel M., et al. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc. Natl Acad. Sci. USA 101 (2004) 14126-14131
41. Wing D.R., Rademacher T.W., Schmitz B., Schachner M., and Dwek R.A. Comparative glycosylation in neural adhesion molecules. Biochem. Soc. Trans. 20 (1992) 386-390
42. Yoshida A., Kobayashi K., Manya H., Taniguchi K., Kano H., Mizuno M., et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 1 (2001) 717-724
43. Zambrowicz B.P., Friedrich G.A., Buxton E.C., Lilleberg S.L., Person C., and Sands A.T. Disruption and sequence identification of 2000 genes in mouse embryonic stem cells. Nature 392 (1998) 608-611